Header Logo

Connection

Okechinyere Achilonu to Triazoles

This is a "connection" page, showing publications Okechinyere Achilonu has written about Triazoles.
Connection Strength

0,178
  1. Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2-P3 a-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach. J Mol Graph Model. 2020 12; 101:107730.
    View in: PubMed
    Score: 0,178
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.